{"schema_version":"secwatch.filing_event.v1","accession":"0001477449-25-000091","form_type":"8-K","ticker":"TDOC","cik":"0001477449","company_name":"Teladoc Health, Inc.","filed_at":"2025-07-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.073139+00:00","generated_at":"2026-05-18T03:19:44.137063+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Teladoc Health enters $300M senior secured revolving credit facility","bullets":["Five-year $300M senior secured revolver with JPMorgan Chase as administrative agent; no immediate borrowings planned.","Interest rates: SOFR + 2.75%-3.25% or base rate + 1.75%-2.25%, based on secured net leverage ratio.","Financial covenants: max secured net leverage 3.50:1 (4.00:1 after certain acquisitions) and min interest coverage 3.00:1.","Proceeds to preserve financial flexibility; capital allocation priorities unchanged (balance sheet, organic/inorganic growth, share repurchases).","Obligations secured by substantially all assets of Teladoc and material domestic/foreign subsidiaries."],"urls":{"canonical":"https://secwatch.observer/filing/0001477449-25-000091","json":"https://secwatch.observer/filing/0001477449-25-000091.json","markdown":"https://secwatch.observer/filing/0001477449-25-000091.md","text":"https://secwatch.observer/filing/0001477449-25-000091.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1477449/000147744925000091/0001477449-25-000091-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1477449/000147744925000091/tdoc-20250717.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T03:19:44.137063+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4ab132f53a9e214cbf0a6b423ec91ad6678442fe","claim":"Teladoc Health, Inc. incurred revolving credit of $300 million with JPMorgan Chase Bank, N.A., as administrative agent at Adjusted Term SOFR plus a margin of 2.75% to 3.25% per annum maturing the fifth anniversary of the Effective Date.","evidence_excerpt":"On July 17, 2025 (the “Effective Date”), Teladoc Health, Inc. (the “Company”) entered into a credit agreement (the “Credit Agreement”) with JPMorgan Chase Bank, N.A., as administrative agent (in such capacity, the “Administrative Agent”), issuing bank and swingline lender, and the lenders party thereto. The Credit Agreement provides for a five-year, $300 million senior secured revolving credit facility (the “Revolving Credit Facility”).","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1477449/000147744925000091/0001477449-25-000091-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"revolving credit"},{"label":"Principal","value":"$300 million"},{"label":"Counterparty","value":"JPMorgan Chase Bank, N.A., as administrative agent"},{"label":"Rate","value":"Adjusted Term SOFR plus a margin of 2.75% to 3.25% per annum"},{"label":"Maturity","value":"the fifth anniversary of the Effective Date"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}